Denosumab
Brand name: Prolia
Rank #92 of 500 drugs by total cost
$199.4M
Total Cost
114,710
Total Claims
$199.4M
Total Cost
3,732
Prescribers
$1,738
Cost per Claim
60,667
Beneficiaries
652,357
30-Day Fills
$53K
Avg Cost/Provider
31
Avg Claims/Provider
About Denosumab
Denosumab (sold as Prolia) was prescribed 114,710 times by 3,732 Medicare Part D providers in 2023, costing the program $199.4M. At $1,738 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 89 | Oxycodone Hcl (Oxycodone Hcl) | $213.2M | 3,537,078 |
| 90 | Brexpiprazole (Rexulti) | $204.0M | 136,378 |
| 91 | Glatiramer Acetate (Copaxone) | $203.6M | 40,986 |
| 92 | Denosumab (Prolia) | $199.4M | 114,710 |
| 93 | Ticagrelor (Brilinta) | $195.8M | 293,897 |
| 94 | Lurasidone Hcl (Latuda) | $190.9M | 254,237 |
| 95 | Darolutamide (Nubeqa) | $188.8M | 14,375 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology